☆ 4.5 Article

RUNX1 predicts poor prognosis and correlates with tumor progression in clear cell renal carcinoma

PATHOLOGY RESEARCH AND PRACTICE (2023)

Related references

Note: Only part of the references are listed.

Review Cell Biology

RUNX3 Meets the Ubiquitin-Proteasome System in Cancer

Albano Toska et al.

Summary: RUNX3 is a transcription factor involved in cell proliferation and development. It can act both as a tumor suppressor and an oncogene in different cancers. The tumor suppressor function of RUNX3 is mainly attributed to its ability to suppress cancer cell proliferation through ubiquitination and proteasomal degradation, while it can also be inactivated through the same mechanism.

CELLS (2023)

Add to Collection

Review Urology & Nephrology

The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours

Holger Moch et al.

Summary: The fifth edition of the WHO classification of urogenital tumours has made significant revisions, including the introduction of molecular-driven renal tumour classification and simplification of the morphologic classification of penile squamous cell carcinomas. A new chapter has also been added for tumours of the scrotum. The main nomenclature for testicular tumours remains the same, but there have been changes in some terms.

EUROPEAN UROLOGY (2022)

Add to Collection

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Medicine, Research & Experimental

Elevated RUNX1 is a prognostic biomarker for human head and neck squamous cell carcinoma

Xiaodong Feng et al.

Summary: The elevated expression of RUNX1 in head and neck squamous cell carcinoma patients is significantly correlated with tumor growth and metastasis. Suppressing RUNX1 can inhibit HNSCC cell proliferation, migration, and invasion, making it a potential biomarker for tumor recurrence and prognosis.

EXPERIMENTAL BIOLOGY AND MEDICINE (2021)

Add to Collection

Article Cell Biology

ACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinoma

Prateek Khanna et al.

Summary: The study suggests that higher ACE2 expression is associated with better overall survival in ccRCC patients and has inhibitory effects on tumor proliferation in vitro and in animal models. Ang-(1-7) may mediate the effects of ACE2. Treatment with VEGFR-TKI decreases ACE2 expression in ccRCC xenografts, and combined therapy with VEGFR-TKI and Ang-(1-7) leads to enhanced tumor growth suppression.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Cell Biology

A Zic2/Runx2/NOLC1 signaling axis mediates tumor growth and metastasis in clear cell renal cell carcinoma

Chen-Yan Wu et al.

Summary: Clear cell renal cell carcinoma (ccRCC) is a common malignancy with rapid growth and high metastasis and lacks effective therapeutic targets. This study demonstrates that the Zic2/Runx2/NOLC1 signaling axis plays a crucial role in promoting ccRCC progression, providing potential therapeutic targets and prognostic indicators. Patients with high Zic2/Runx2 and low NOLC1 expression have the worst outcomes according to Kaplan-Meier survival analyses.

CELL DEATH & DISEASE (2021)

Add to Collection

Article Oncology

RUNX1 regulates the proliferation and chemoresistance of colorectal cancer through the Hedgehog signaling pathway

Qingyuan Li et al.

Summary: In this study, RUNX1 expression was found to be upregulated in colorectal cancer tissues, promoting cancer cell proliferation and chemoresistance by activating the Hedgehog signaling pathway and increasing ABCG2 expression.

JOURNAL OF CANCER (2021)

Add to Collection

Review Urology & Nephrology

Clear cell renal cell carcinoma ontogeny and mechanisms of lethality

Eric Jonasch et al.

Summary: The molecular features that define the initiation and progression of clear cell renal cell carcinoma (ccRCC) are increasingly being understood. Common genomic and chromosomal copy number abnormalities in ccRCC can be categorized into initiating events, drivers of progression, and factors that confer lethality. Mutations in specific genes in ccRCC may affect genomic stability and immune cell populations within tumors.

NATURE REVIEWS NEPHROLOGY (2021)

Add to Collection

Article Hematology

High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML

Laura Simon et al.

BLOOD (2020)

Add to Collection

Article Genetics & Heredity

Runx2 is essential for the transdifferentiation of chondrocytes into osteoblasts

Xin Qin et al.

PLOS GENETICS (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

Integration of transcriptome and cistrome analysis identifies RUNX1-target genes involved in pancreatic cancer proliferation

Songsong Liu et al.

GENOMICS (2020)

Add to Collection

Article Oncology

RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation

Nan Zhou et al.

LEUKEMIA (2019)

Add to Collection

Review Urology & Nephrology

The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications

W. Marston Linehan et al.

NATURE REVIEWS UROLOGY (2019)

Add to Collection

Article Multidisciplinary Sciences

Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis

Yang Fu et al.

PEERJ (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Emerging role of RUNX3 in the regulation of tumor microenvironment

Sarala Manandhar et al.

BMB REPORTS (2018)

Add to Collection

Article Cell Biology

RUNX1 Regulates Migration, Invasion, and Angiogenesis via p38 MAPK Pathway in Human Glioblastoma

Kant Sangpairoj et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2017)

Add to Collection

Review Hematology

Role of RUNX1 in hematological malignancies

Raman Sood et al.

BLOOD (2017)

Add to Collection

Article Developmental Biology

Runx3-Regulated Expression of Two Ntrk3 Transcript Variants in Dorsal Root Ganglion Neurons

Yuuki Ogihara et al.

DEVELOPMENTAL NEUROBIOLOGY (2016)

Add to Collection

Review Urology & Nephrology

Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer

Johannes Schoedel et al.

EUROPEAN UROLOGY (2016)

Add to Collection

Article Cell & Tissue Engineering

Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells

Xiongwei Cai et al.

CELL STEM CELL (2015)

Add to Collection

Review Oncology

The RUNX family: developmental regulators in cancer

Yoshiaki Ito et al.

NATURE REVIEWS CANCER (2015)

Add to Collection

Review Oncology

RUNX family: Regulation and diversification of roles through interacting proteins

Linda Shyue Huey Chuang et al.

INTERNATIONAL JOURNAL OF CANCER (2013)

Add to Collection

Review Urology & Nephrology

The complex roles of Wnt antagonists in RCC

Sharanjot Saini et al.

NATURE REVIEWS UROLOGY (2011)

Add to Collection

Article Multidisciplinary Sciences

Resistance of Renal Cell Carcinoma to Sorafenib Is Mediated by Potentially Reversible Gene Expression

Liang Zhang et al.

PLOS ONE (2011)

Add to Collection

Review Biochemistry & Molecular Biology

RUNX3 is multifunctional in carcinogenesis of multiple solid tumors

L. S. H. Chuang et al.

ONCOGENE (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.